Table 1.
Demographic characteristics of the study population.
| Characteristics | Vi-DT Group | Placebo Group | Total | |
|---|---|---|---|---|
| Overall | N = 228 | N = 57 | N = 285 | |
| Gender | Male (%) | 109 (47.8) | 29 (50.9) | 138 (48.42) |
| Female (%) | 119 (52.2) | 28 (49.1) | 147 (51.58) | |
| Age (months) | Mean (SD) | 11.56 (5.45) | 11.35 (5.14) | 11.52 (5.38) |
| Median (min, max) | 9 (6, 23) | 9 (6, 23) | 9 (6, 23) | |
| 6 to less than 9 months | N = 76 | N = 19 | N = 95 | |
| Gender | Male (%) | 32 (42.1) | 11 (57.9) | 43 (45.26) |
| Female (%) | 44 (57.9) | 8 (42.1) | 52 (54.74) | |
| Age (months) | Mean (SD) | 6.83 (0.87) | 6.79 (0.71) | 6.82 (0.84) |
| Median (min, max) | 7 (6, 8) | 7 (6, 8) | 7 (6, 8) | |
| 9 to 12 months | N = 76 | N = 19 | N = 95 | |
| Gender | Male (%) | 39 (51.3) | 9 (47.4) | 48 (50.53) |
| Female (%) | 37 (48.7) | 10 (52.6) | 47 (49.47) | |
| Age (months) | Mean (SD) | 9.25 (0.64) | 9.42 (0.96) | 9.28 (0.71) |
| Median (min, max) | 9 (8, 12) | 9 (9, 12) | 9 (8, 12) | |
| 13 to 23 months | N = 76 | N = 19 | N = 95 | |
| Gender | Male (%) | 38 (50.0) | 9 (47.4) | 47 (49.47) |
| Female (%) | 38 (50.0) | 10 (52.6) | 48 (50.53) | |
| Age (months) | Mean (SD) | 18.59 (3.24) | 17.84 (3.24) | 18.44 (3.24) |
| Median (min, max) | 19 (13, 23) | 19 (13, 23) | 19 (13, 23) | |